Kim Sweeney, PharmD

Senior Director, Medical Affairs

Kim Sweeney, PharmD currently serves as Senior Director, Medical Affairs. Dr. Sweeney brings over 15 years of Medical Affairs experience including publication planning, thought leader development and management, Phase IV planning, as well as medical science liaison team development and training.  Dr. Sweeney has contributed to the development of multiple injectable infectious disease programs including: Maxipime®, Azactam®, Minocin®, Orbactiv®, and Carbavance™. Prior to joining Zavante, Dr. Sweeney was with The Medicines Company as Director, Global Medical Affairs. In addition, Dr. Sweeney has held senior level positions with Elan Pharmaceuticals, Cadence Pharmaceuticals, and The Institute for Clinical Pharmacodynamics.

Dr. Sweeney holds a Pharm D from Rutgers College of Pharmacy, and conducted her post-doctorate infectious disease training at Thomas Jefferson University Hospital and Bristol-Myers Squibb, Infectious Disease Medical Operations.